DENVER, Oct. 11 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today reported that its Wyndgate Technologies(R) ("Wyndgate"), division will be a key exhibitor at the AABB Annual Meeting and Transfusion Medicine Expo (TXPO).
The AABB, founded in 1947, is a leader in the development of standards for voluntary compliance in blood bank component and collection, processing and transfusion. According to the AABB, more than 180 TXPO exhibitors will demonstrate and deliver the latest information on the most innovative products, services and technologies for the blood banking, transfusion and cellular therapy communities. The annual meeting will be held at the Anaheim Convention Center in Anaheim, California, from October 20th through October 23rd. This will be Wyndgate's thirteenth consecutive year as a supporter, exhibitor and sponsor of the conference. Wyndgate's well-staffed exhibit will be in Booth 355.
"With individuals from more than 88 countries attending, AABB TXPO is Wyndgate's most important annual domestic and international conference," stated Mick Ruxin, M.D., Chairman and CEO of Global Med Technologies. "In addition to presenting our own innovative technology, we are excited to be hosting Gambro BCT, as well as a major LIS partner within our exhibit." Dr. Ruxin continued, "We congratulate AABB on their 60th anniversary and salute their important work in developing standards for blood management and providing continuing education to professionals in the blood industry."
Safe Blood International, Global Med's partner in HIV/AIDS prevention work in Africa, will be participating in the conference. James van Hasselt, M.D., of Safe Blood International, will be moderating "Blood Supplies and Use in Resource Constrained Nations." Safe Blood is an emerging leader in safeguarding the blood supply in multiple countries within sub-Saharan Africa where contamination from infectious, blood borne diseases, including HIV, Hepatitis B and Hepatitis C, is widespread. Currently, several sub-Saharan sites use Wyndgate products and services.
In addition to being an exhibitor at AABB, Wyndgate will be contributing to the event as a sponsor of the National Blood Foundation (NBF) Golf Tournament. The tournament aids in raising funds to support research and education initiatives for advancing transfusion medicine, blood banking and cellular therapies.
AABB is an international, not-for-profit association consisting of approximately 8,000 individuals and 2,000 institutions. The association and its members promote the voluntary donation of blood. Its member facilities are responsible for collecting virtually all of the nation's blood supply and transfusing more than 80 percent. AABB's Annual Meeting and TXPO gathers professionals from over 88 countries to peer network, view the latest in blood management technology and receive information from more than 130 educational and abstract offerings.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved